Altogether these mitochondrial changes resulted in a dramatic increase of FGF21 in muscle and serum (100 fold, Table 1), its range has been reported in patients with mitochondrial diseases (Morovat et al., 2017) and unhealthy aging (Conte et al., 2018). Here, FGF21 is linked to inborn mitochondrial metabolism disorder.